Other members of the BCL2 family of proteins also carry tumor-associated alterations that tip the intracellular balance towards an anti-apoptotic state, e.g., Bim deletion in mantle cell lymphoma (MCL) or Noxa mutations in DLBCL [88,89]. This evidence concerns the gene BCL2 and mantle cell lymphoma.